Gu and Zhou [19] demonstrated that 80 μM BBR significantly suppressed the proliferation and colony formation of human endometrial stromal cells by downregulating the expression of miR-429 and inhibiting the expression of the PCNA protein, which provided a theoretical basis for using BBR to treat EM. The gene discussed is PCNA; the disease is erythema multiforme.